← Leaderboards
Genevieve Claire Kendall
Research Inst Nationwide Children'S Hosp
$1,673,106
Attributed
$1,673,106
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $460.4K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,673,106 · 1
By mechanism
R01$1,673,106 · 1
Top collaborators
No co-investigators on record.
Most similar at Research Inst Nationwide Children'S Hosp
Same institution · by research overlap
- Ruoning Wang$11,278,033
Others in their field
Other Rising Stars on “Actins”
- Raul Padron · Univ Of Massachusetts Med Sch Worcester$4,501,962
- Baodong Sun · Duke University$2,697,948
- Lindsay Case · Massachusetts Institute Of Technology$2,381,060
- Qing Tang · University Of Nebraska Lincoln$2,041,875
- Callie S Kwartler · University Of Texas Hlth Sci Ctr Houston$1,962,238
- Ryan David Wuebbles · Strykagen Corporation$1,953,245
Research focus
ActinsAffectAllograftingAdp-Ribosylation Factor 6Animal ModelAnimalsBindingBiochemicalAlveolar RhabdomyosarcomaCancer BiologyCancer ModelCell Culture TechniquesCell LineCell LineageCellsChemotherapyChildChildhoodChromatinBiologyClinical CareClinical SequencingComparativeComplex
Grant awards (7)
Understanding Infantile Rhabdomyosarcoma Biology and Therapeutic Targets$382,872
R01 · FY2025 · CA · contact PI
Understanding Infantile Rhabdomyosarcoma Biology and Therapeutic Targets$71,772
R01 · FY2025 · CA · contact PI
Understanding Infantile Rhabdomyosarcoma Biology and Therapeutic Targets$363,728
R01 · FY2024 · CA · contact PI
Understanding Infantile Rhabdomyosarcoma Biology and Therapeutic Targets$68,183
R01 · FY2024 · CA · contact PI
Understanding Infantile Rhabdomyosarcoma Biology and Therapeutic Targets$28,465
R01 · FY2024 · CA · contact PI
Understanding Infantile Rhabdomyosarcoma Biology and Therapeutic Targets$375,214
R01 · FY2023 · CA · contact PI
Understanding Infantile Rhabdomyosarcoma Biology and Therapeutic Targets$382,872
R01 · FY2022 · CA · contact PI